| Title: | Implications for retail pharmacies |
| Alternate title: | Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives |
| Author: | Jaggar, Sarah F. |
| Author: | United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations |
| Author: | United States. General Accounting Office |
| Note: | The Office ;, 1996 |
| Link: | page images at HathiTrust |
| No stable link: | This is an uncurated book entry from our extended bookshelves, readable online now but without a stable link here. You should not bookmark this page, but you can request that we add this book to our curated collection, which has stable links. |
| Subject: | Drug Costs |
| Subject: | Drugs -- Prices -- United States |
| Subject: | Drugstores -- United States |
| Subject: | Prescription pricing -- United States |
| Other copies: | Look for editions of this book at your library, or elsewhere. |
Help with reading books -- Report a bad link -- Suggest a new listing
Home -- Search -- New Listings -- Authors -- Titles -- Subjects -- Serials
Books -- News -- Features -- Archives -- The Inside Story
Edited by John Mark Ockerbloom (onlinebooks@pobox.upenn.edu)
OBP copyrights and licenses.